Home
Live Updates
Inhibrx Announces Participation in Upcoming Scientific Conferences : comparemela.com
Inhibrx Announces Participation in Upcoming Scientific Conferences
/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare...
Related Keywords
Colorado ,
United States ,
Boston ,
Massachusetts ,
Canada ,
Vancouver ,
British Columbia ,
American ,
Bryan Becklund ,
Vivek Subbiah ,
Pharmacometrics Aco ,
Robin Lewisl Jones ,
Santp Chawla ,
Bristol Myers Squibb ,
Nehalj Lakhani ,
Sharvari Bhagwat ,
Prnewswire Inhibrx Inc ,
Society For Immunotherapy Of Cancer ,
Connective Tissue Oncology Society ,
Inhibrx Inc ,
Nasdaq ,
Fusion Protein ,
Molecular Targeted Cytokine ,
Potentiates Anti Tumor ,
Tissue Oncology Society ,
Updated Efficacy ,
Tetravalent Death Receptor ,
Present Virtual Poster Presentation ,
Ewing Sarcoma ,
Preclinical Rationale ,
Combination Expansion ,
Placebo Controlled Phase ,
Metastatic Conventional ,
Robin Lewis ,
Media Contact ,
comparemela.com © 2020. All Rights Reserved.